PBYI — PUMA BIOTECHNOLOGY INC

Ownership history in Athyrium Capital Management, LP  ·  11 quarters on record

This page tracks every 13F SEC filing in which Athyrium Capital Management, LP reported a position in PUMA BIOTECHNOLOGY INC (PBYI). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
36.88% (2024 Q3)
Avg. % of fund
8.05%
First filed
2022 Q1
Last filed
2024 Q3
Quarters held
11
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2024 Q3 UNCHANGED 1,256,411 — 0% 36.88% $3.20B $2.55
2024 Q2 UNCHANGED 1,256,411 — 0% 12.21% $4.10B $3.26
2024 Q1 REDUCED 1,256,411 -535,703 -29.9% 9.15% $6.66B $5.30
2023 Q4 UNCHANGED 1,792,114 — 0% 11.27% $7.76B $4.33
7 older quarters hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    PBYI price (monthly, adj. close)

Other funds also holding PBYI

As of 2025 Q4 — sorted by position size

ACORN CAPITAL ADVISORS, LLC 8.33% GLOBEFLEX CAPITAL L P 3Y 7Y 0.41% Verdad Advisers, LP 3Y 0.38% VIRTUS ADVISERS, LLC 3Y 7Y 0.13% C2C Wealth Management, LLC 3Y 0.12% KENNEDY CAPITAL MANAGEMENT LLC 3Y 7Y 0.11% BRIDGEWAY CAPITAL MANAGEMENT, LLC 3Y 7Y 0.1% Round Rock Advisors LLC 3Y 0.09% EntryPoint Capital, LLC 0.08% RITHOLTZ WEALTH MANAGEMENT 3Y 7Y 0.08%
← Back to Athyrium Capital Management, LP Holdings